JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Young, A. M.
Right arrow Articles by Woods, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Young, A. M.
Right arrow Articles by Woods, J. H.

Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories

AM Young and JH Woods

Rhesus monkeys lever-pressed under a fixed-ratio 30 time-out 600 sec schedule of i.v. injection of codeine (0.32 mg/kg/injection) or, in a second group of monkeys, ketamine (1.0 mg/kg/injection). During single session substitutions, the maintenance drug was replaced with saline or doses of various other drugs. At appropriate doses, ketamine maintained responding when substituted for ketamine. Phencyclidine, dexoxadrol and dextrorphan maintained responding when substituted for ketamine but did not maintain responding when substituted for codeine. Cyclazocine and SKF-10,047 (N-allyl-normetazocine) did not maintain responding when substituted for either ketamine or codeine; ethylketazocine did not maintain responding when substituted for ketamine. For those drugs maintained under behavior, fixed-ratio response rate and the number of injection dose and then decreased at higher injection doses. Substituted drugs maintained maximum response rates at the following injection doses: codeine, 0.32 mg/kg; ketamine, 1.0 mg/kg; phencyclidine, 0.03 mg/kg, dexoxadrol, 0.32 mg/kg; and dextrorphan, 1.0 mg/kg. Under only the ketamine maintenance schedule, the rate of responding during the timeout component varied as a function of the substitution dose of ketamine, codeine, phencyclidine and dexoxadrol, with the dose that maintained maximal fixed-ratio rates also engendering the highest rates of timeout responding.

Volume 218, Issue 3, pp. 720-727, 09/01/1981
Copyright © 1981 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
G. T. Collins and J. H. Woods
Drug and Reinforcement History as Determinants of the Response-Maintaining Effects of Quinpirole in the Rat
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 599 - 605.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
G. Winger, S. R. Hursh, K. L. Casey, and J. H. Woods
Relative Reinforcing Strength of Three N-Methyl-D-Aspartate Antagonists with Different Onsets of Action
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 690 - 697.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
J. H. Krystal, I. L. Petrakis, E. Webb, N. L. Cooney, L. P. Karper, S. Namanworth, P. Stetson, L. A. Trevisan, and D. S. Charney
Dose-Related Ethanol-like Effects of the NMDA Antagonist, Ketamine, in Recently Detoxified Alcoholics
Arch Gen Psychiatry, April 1, 1998; 55(4): 354 - 360.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics.